Collegium Expands Commercial Organization With Key Appointments

Go back to Collegium Expands Commercial Organization With Key Appointments

Collegium Pharma (COLL) Appoints New Chief Commercial Officer and Two New VPs

June 1, 2015 7:18 AM UTC

Collegium Pharma (NASDAQ: COLL) announced the addition of Barry Duke as Executive Vice President and Chief Commercial Officer. In addition to Mr. Duke, Mary Ogle joined as Vice President of Marketing and Timothy Hermes as Vice President of Government Affairs and Alliance Development.

"Barry's deep experience, in both small and large organizations make him a great fit to lead our commercial organization as we prepare for FDA approval and launch of Xtampza ER." said... More